6.9.2 Hypothyroidism

Combination levothyroxine and liothyronine should not be used routinely in the management of hypothyroidism as there is insufficient population based clinical evidence to show that combination therapy is superior to levothyroxine monotherapy. It may be initiated by an NHS Consultant Endocrinologist ONLY in circumstances where all other treatment options have been exhausted:

1. Where symptoms of hypothyroidism persist despite optimal dosage with levothyroxine. (TSH 0.4-1.5mU/L)

2. Where alternative causes of symptoms have been excluded.

Hypothyroidism should be treated first line with Levothyroxine.
Liothyronine monotherapy is not recommended in hypothyroidism and should only be prescribed in exceptional circumstances, in line with RMOC/JPC guidance.

Expand All / Expand All (incl. cost)

Levothyroxine solution is a high cost preparation and should be reserved ONLY for paediatric use if crushing tablets is inappropriate. Levothyroxine tablets may be crushed and dispersed in water for administration via enteral tubes or for patients with swallowing difficulties (Reference: NEWT guidelines accessed July 2016).

Pack Price
100 tablet
28 tablet £0.77
500 tablet
Pack Price
100 tablet
1000 tablet
28 tablet £0.68
84 tablet
Pack Price
100 tablet
1000 tablet
28 tablet £0.69
84 tablet
Pack Price
100 ml £94.99
Pack Price
100 ml £89.00
Pack Price
100 ml £164.99
Pack Price
1 tablet
100 tablet
28 tablet £123.38
Pack Price
1 tablet
28 tablet £152.44
Pack Price
100 tablet
28 tablet £40.10
Pack Price
5 vial £1,567.50
Pack Price
100 tablet
Pack Price
100 tablet
Pack Price
100 tablet
Pack Price
100 tablet
Pack Price
100 tablet
Pack Price
100 tablet